BVI Medical
Devang Shah has held various leadership roles in the medical industry, including positions at BVI Medical and CR Bard. With a background in research and development, regulatory affairs, and quality assurance, Devang has also served as an Adjunct Faculty at Northeastern University. Devang holds a Ph.D. in Molecular Biology from Northeastern University, an MBA from MIT Sloan School of Management, a Master's in Biological & Chemical Engineering from Tufts University, and a B.S. in Biomedical Engineering from Worcester Polytechnic Institute.
BVI Medical
1 followers
BVI® is refocusing the future of vision. As one of the fastest-growing, diversified surgical ophthalmic businesses in the world, our purpose-built portfolio of trusted brands includes: Beaver® (Knives and Blades), Visitec® (Cannulas), Malosa® (Single-Use Instruments), Vitreq® (Vitreoretinal Surgical Products) and PhysIOL® (Premium IOLs), and spans more than 90 countries. We’ve set our sights on touching the lives of millions of patients affected by conditions such as cataracts, refractive error, glaucoma, retinal disease, and dry eye. Unburdened by legacy or bureaucracy, we have developed our strategy around a simple concept – taking pride in delivering innovative solutions for our physicians and patients, based on their needs. We trust and empower our associates to make decisions and solve problems because collaboration drives us. Valuing agility, simplicity, and transparency, we stay committed to listening to our customers, delivering for our patients, and keeping the future in focus.